Switching from Reference Medicines to Biosimilars
Realizing the Promise of Pharmacy Benefit Biosimilars in the U.S.
Sponsored by Sandoz Inc. (A Novartis Division)
Thursday, July 23, 2020, 2-3pm ET
In this webinar, Hillel Cohen, will discuss biosimilar switching studies, including updates on newer studies and recent analyses. We will review what is known about safety, effectiveness, immunogenicity, and multiple switching events.
- Hillel P. Cohen, PhD
Executive Director, Scientific Affairs
Sandoz Inc. (a Novartis Division)
This webinar is sponsored, developed and presented by the sponsor. The content of this Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.
** IMPORTANT: AMCP webinars are limited to the first 1000 that join the webinar. The recording and slides of sponsored webinars will be provided if permitted by the sponsor.
For individuals from the media/press who are interested in attending, please email email@example.com.